ZIVO Bioscience, Inc. - SIC # 2840 -

Ticker Exchange SIC # Website Latest Ticker
ZIVO Over the counter 2840 www.zivobioscience.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for ZIVO Bioscience, Inc.

ZIVO Bioscience Reports Progress with Coccidiosis Treatment Licensing Opportunities - Dec 23rd, 2024 1:00 pm
ZIVO Bioscience Reports Preliminary Efficacy of its Proprietary Active Ingredients in the Battle Against Avian Influenza - Dec 20th, 2024 2:29 pm
Director and 10% Owner Christopher Maggiore Acquires 31,336 Shares of Zivo Bioscience Inc (ZIVO) - Aug 23rd, 2024 11:01 pm
ZIVO Reports Favorable Results from 42-Day Confirmatory Study of its Coccidiosis Treatment in Broiler Chickens - Aug 23rd, 2024 3:39 pm
Major Global Animal Health Company Launches 42-Day Confirmatory Study with ZIVO Bioscience’s Coccidiosis Treatment in Broiler Chickens - Jul 8th, 2024 12:00 pm
ZIVO Bioscience Reports Additional Findings from Positive 42-Day Coccidiosis Challenge Study - Feb 7th, 2024 9:54 pm
ZIVO Bioscience Announces Uplisting to OTCQB Market - Jan 29th, 2024 1:00 pm
ZIVO Bioscience Reports Positive Efficacy Results from 42-Day Validation Study with Non-Antibiotic Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens - Jan 23rd, 2024 1:00 pm